Medpace

Medpace is a full-service contract research organization (CRO) dedicated to accelerating the development of safe and effective medical therapeutics. The company operates under a therapeutically-focused, integrated model that provides sponsors with early and ongoing insight from medical experts throughout trial design and execution.

Core Services

Medpace offers comprehensive clinical research services spanning all phases of development:

• Clinical Operations & Trial Management: Study start-up, clinical trial management, sites and patient recruitment, patient diversity in clinical trials, decentralized clinical trials, clinical monitoring, and clinical packaging & supplies.
• Data & Biostatistics: Biostatistics and data management, medical affairs, clinical safety and pharmacovigilance, regulatory affairs and medical writing, and quality assurance.
• Laboratory Services: Fully-integrated central and bioanalytical laboratory services, including biomarker assays, safety testing, discovery and development support, preclinical studies, PK/TK studies, ADA assays, neutralizing antibody assays, and bioanalytical assays.
• Imaging & Cardiac Safety: Core Labs providing end-to-end global cardiac safety and imaging services, including cardiovascular and ECG core lab services, wearable biosensor technology, and a Phase I Unit.
• Therapeutic Expertise: Deep capabilities across cardiovascular, dermatology, endocrine & metabolic, gastroenterology & hepatology, hematology & oncology, immunology & inflammation, infectious diseases & vaccines, nephrology, neuroscience, ophthalmology, respiratory, and rheumatology. Specialized crossover services include rare diseases, cell & gene therapy, radiation therapy & radiopharmaceuticals, pediatrics, transplantation, and women's health.

Differentiation

Medpace emphasizes organic growth over 30+ years, maintaining team continuity and avoiding disruptions from mergers and acquisitions. The company operates a full-service outsourcing model with wholly-owned central laboratories, bioanalytical lab, imaging core lab, ECG core lab, and Phase I Unit, integrated via a unified Clinical Trial Management System. This integrated approach aims to deliver higher efficiency and productivity while maintaining quality and seamless execution across complex clinical trials.